1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 ACE Inhibitors 1.2.3 Angiotensin-II Receptor Blockers 1.2.4 Calcium Channel Blockers 1.2.5 Beta Blockers: BREVIBLOC, Bystolic 1.2.6 Others 1.3 Market Segment by Application 1.3.1 Global Chronic Kidney Disease (CKD) Drugs Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Hospitals 1.3.3 Specialty Clinics 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Chronic Kidney Disease (CKD) Drugs Market Size (2017-2028) 2.1.1 Global Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) 2.1.2 Global Chronic Kidney Disease (CKD) Drugs Sales (2017-2028) 2.2 Global Chronic Kidney Disease (CKD) Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Regions (2017-2022) 2.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Regions (2017-2022) 2.3 Global Chronic Kidney Disease (CKD) Drugs Market Size Forecast by Region 2.3.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Region (2023-2028) 2.3.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Region (2023-2028) 2.4 Global Top Chronic Kidney Disease (CKD) Drugs Regions (Countries) Ranking by Market Size 2.5 Chronic Kidney Disease (CKD) Drugs Market Dynamics 2.5.1 Chronic Kidney Disease (CKD) Drugs Market Trends 2.5.2 Chronic Kidney Disease (CKD) Drugs Market Drivers 2.5.3 Chronic Kidney Disease (CKD) Drugs Market Challenges 2.5.4 Chronic Kidney Disease (CKD) Drugs Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Chronic Kidney Disease (CKD) Drugs Manufacturers by Sales (2017-2022) 3.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers (2017-2022) 3.1.2 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Chronic Kidney Disease (CKD) Drugs Sales in 2021 3.2 Global Top Manufacturers Chronic Kidney Disease (CKD) Drugs by Revenue 3.2.1 Global Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Top Chronic Kidney Disease (CKD) Drugs Manufacturers Covered: Ranking by Revenue 3.2.3 Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Chronic Kidney Disease (CKD) Drugs Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Drugs as of 2021) 3.4 Global Chronic Kidney Disease (CKD) Drugs Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Chronic Kidney Disease (CKD) Drugs Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market 3.7 Key Manufacturers Chronic Kidney Disease (CKD) Drugs Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Chronic Kidney Disease (CKD) Drugs Market Size by Type 4.1 Global Chronic Kidney Disease (CKD) Drugs Historic Market Review by Type (2017-2022) 4.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2022) 4.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2017-2022) 4.1.3 Chronic Kidney Disease (CKD) Drugs Price by Type (2017-2022) 4.2 Global Chronic Kidney Disease (CKD) Drugs Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Type (2023-2028) 4.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Type (2023-2028) 4.2.3 Chronic Kidney Disease (CKD) Drugs Price Forecast by Type (2023-2028) 5 Global Chronic Kidney Disease (CKD) Drugs Market Size by Application 5.1 Global Chronic Kidney Disease (CKD) Drugs Historic Market Review by Application (2017-2022) 5.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2022) 5.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application (2017-2022) 5.1.3 Chronic Kidney Disease (CKD) Drugs Price by Application (2017-2022) 5.2 Global Chronic Kidney Disease (CKD) Drugs Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Application (2023-2028) 5.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Application (2023-2028) 5.2.3 Chronic Kidney Disease (CKD) Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Company 6.1.1 North America Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) 6.1.2 North America Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) 6.2 North America Chronic Kidney Disease (CKD) Drugs Market Size by Type 6.2.1 North America Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2028) 6.2.2 North America Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2028) 6.3 North America Chronic Kidney Disease (CKD) Drugs Market Size by Application 6.3.1 North America Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2028) 6.3.2 North America Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2028) 6.4 North America Chronic Kidney Disease (CKD) Drugs Market Size by Country 6.4.1 North America Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2028) 6.4.2 North America Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2028) 6.4.3 United States 6.4.4 Canada 6.4.5 Mexico 7 Europe 7.1 Europe Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Company 7.1.1 Europe Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) 7.1.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) 7.2 Europe Chronic Kidney Disease (CKD) Drugs Market Size by Type 7.2.1 Europe Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2028) 7.2.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2028) 7.3 Europe Chronic Kidney Disease (CKD) Drugs Market Size by Application 7.3.1 Europe Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2028) 7.3.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2028) 7.4 Europe Chronic Kidney Disease (CKD) Drugs Market Size by Country 7.4.1 Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2028) 7.4.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 UK 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Company 8.1.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) 8.1.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) 8.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Size by Type 8.2.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2028) 8.2.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2028) 8.3 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Size by Application 8.3.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2028) 8.3.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2028) 8.4 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Size by Region 8.4.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Region 8.4.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Indonesia 8.4.9 Thailand 8.4.10 Malaysia 8.4.11 Philippines 8.4.12 Vietnam 9 Latin America 9.1 Latin America Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Company 9.1.1 Latin America Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) 9.1.2 Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) 9.2 Latin America Chronic Kidney Disease (CKD) Drugs Market Size by Type 9.2.1 Latin America Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2028) 9.2.2 Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2028) 9.3 Latin America Chronic Kidney Disease (CKD) Drugs Market Size by Application 9.3.1 Latin America Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2028) 9.3.2 Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2028) 9.4 Latin America Chronic Kidney Disease (CKD) Drugs Market Size by Country 9.4.1 Latin America Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2028) 9.4.2 Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Company 10.1.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) 10.1.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) 10.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Size by Type 10.2.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2028) 10.2.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2028) 10.3 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Size by Application 10.3.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2028) 10.3.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2028) 10.4 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Size by Country 10.4.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2028) 10.4.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Company Profiles 11.1 Pfizer, Inc. 11.1.1 Pfizer, Inc. Corporation Information 11.1.2 Pfizer, Inc. Overview 11.1.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Products and Services 11.1.5 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs SWOT Analysis 11.1.6 Pfizer, Inc. Recent Developments 11.2 Amgen 11.2.1 Amgen Corporation Information 11.2.2 Amgen Overview 11.2.3 Amgen Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 Amgen Chronic Kidney Disease (CKD) Drugs Products and Services 11.2.5 Amgen Chronic Kidney Disease (CKD) Drugs SWOT Analysis 11.2.6 Amgen Recent Developments 11.3 Roche 11.3.1 Roche Corporation Information 11.3.2 Roche Overview 11.3.3 Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 Roche Chronic Kidney Disease (CKD) Drugs Products and Services 11.3.5 Roche Chronic Kidney Disease (CKD) Drugs SWOT Analysis 11.3.6 Roche Recent Developments 11.4 GlaxoSmithKline (GSK) 11.4.1 GlaxoSmithKline (GSK) Corporation Information 11.4.2 GlaxoSmithKline (GSK) Overview 11.4.3 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Products and Services 11.4.5 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs SWOT Analysis 11.4.6 GlaxoSmithKline (GSK) Recent Developments 11.5 Allergan 11.5.1 Allergan Corporation Information 11.5.2 Allergan Overview 11.5.3 Allergan Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Allergan Chronic Kidney Disease (CKD) Drugs Products and Services 11.5.5 Allergan Chronic Kidney Disease (CKD) Drugs SWOT Analysis 11.5.6 Allergan Recent Developments 11.6 AbbVie 11.6.1 AbbVie Corporation Information 11.6.2 AbbVie Overview 11.6.3 AbbVie Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 AbbVie Chronic Kidney Disease (CKD) Drugs Products and Services 11.6.5 AbbVie Chronic Kidney Disease (CKD) Drugs SWOT Analysis 11.6.6 AbbVie Recent Developments 11.7 Kissei Pharmaceutical Co., Ltd. 11.7.1 Kissei Pharmaceutical Co., Ltd. Corporation Information 11.7.2 Kissei Pharmaceutical Co., Ltd. Overview 11.7.3 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Products and Services 11.7.5 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs SWOT Analysis 11.7.6 Kissei Pharmaceutical Co., Ltd. Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Chronic Kidney Disease (CKD) Drugs Value Chain Analysis 12.2 Chronic Kidney Disease (CKD) Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Chronic Kidney Disease (CKD) Drugs Production Mode & Process 12.4 Chronic Kidney Disease (CKD) Drugs Sales and Marketing 12.4.1 Chronic Kidney Disease (CKD) Drugs Sales Channels 12.4.2 Chronic Kidney Disease (CKD) Drugs Distributors 12.5 Chronic Kidney Disease (CKD) Drugs Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of ACE Inhibitors Table 3. Major Manufacturers of Angiotensin-II Receptor Blockers Table 4. Major Manufacturers of Calcium Channel Blockers Table 5. Major Manufacturers of Beta Blockers: BREVIBLOC, Bystolic Table 6. Major Manufacturers of Others Table 7. Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Chronic Kidney Disease (CKD) Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 9. Global Chronic Kidney Disease (CKD) Drugs Sales by Region (2017-2022) & (K Units) Table 10. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region (2017-2022) Table 11. Global Chronic Kidney Disease (CKD) Drugs Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Region (2017-2022) Table 13. Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Region (2023-2028) & (K Units) Table 14. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share Forecast by Region (2023-2028) Table 15. Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 16. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share Forecast by Region (2023-2028) Table 17. Top Chronic Kidney Disease (CKD) Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 18. Chronic Kidney Disease (CKD) Drugs Market Trends Table 19. Chronic Kidney Disease (CKD) Drugs Market Drivers Table 20. Chronic Kidney Disease (CKD) Drugs Market Challenges Table 21. Chronic Kidney Disease (CKD) Drugs Market Restraints Table 22. Global Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers (2017-2022) & (K Units) Table 23. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers (2017-2022) Table 24. Global Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2017-2022) & (US$ Million) Table 25. Ranking of Global Top Chronic Kidney Disease (CKD) Drugs Manufacturers by Revenue (US$ Million) in 2021 Table 26. Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2017-2022) Table 27. Global Chronic Kidney Disease (CKD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Drugs as of 2021) Table 29. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Unit) Table 30. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Plants/Factories Distribution Table 31. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Area Served Table 32. Date of Key Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market Table 33. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Chronic Kidney Disease (CKD) Drugs Sales (K Units) by Type (2017-2022) Table 36. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Type (2017-2022) Table 37. Global Chronic Kidney Disease (CKD) Drugs Revenue (US$ Million) Market Share by Type (2017-2022) Table 38. Global Chronic Kidney Disease (CKD) Drugs Price (K Units) by Type (2017-2022) Table 39. Global Chronic Kidney Disease (CKD) Drugs Sales (K Units) by Type (2023-2028) Table 40. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Type (2023-2028) Table 41. Global Chronic Kidney Disease (CKD) Drugs Revenue (US$ Million) Market Share by Type (2023-2028) Table 42. Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Type (2023-2028) Table 43. Global Chronic Kidney Disease (CKD) Drugs Price (K Units) by Type (2023-2028) Table 44. Global Chronic Kidney Disease (CKD) Drugs Sales (K Units) by Application (2017-2022) Table 45. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Application (2017-2022) Table 46. Global Chronic Kidney Disease (CKD) Drugs Revenue (US$ Million) Market Share by Application (2017-2022) Table 47. Global Chronic Kidney Disease (CKD) Drugs Price (K Units) by Application (2017-2022) Table 48. Global Chronic Kidney Disease (CKD) Drugs Sales (K Units) by Application (2023-2028) Table 49. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Application (2023-2028) Table 50. Global Chronic Kidney Disease (CKD) Drugs Revenue (US$ Million) Market Share by Application (2023-2028) Table 51. Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Application (2023-2028) Table 52. Global Chronic Kidney Disease (CKD) Drugs Price (K Units) by Application (2023-2028) Table 53. North America Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) & (K Units) Table 54. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company (2017-2022) Table 55. North America Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) & (US$ Million) Table 56. North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2017-2022) Table 57. North America Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units) Table 58. North America Chronic Kidney Disease (CKD) Drugs Sales by Type (2023-2028) & (K Units) Table 59. North America Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 60. North America Chronic Kidney Disease (CKD) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 61. North America Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units) Table 62. North America Chronic Kidney Disease (CKD) Drugs Sales by Application (2023-2028) & (K Units) Table 63. North America Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 64. North America Chronic Kidney Disease (CKD) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 65. North America Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022) & (K Units) Table 66. North America Chronic Kidney Disease (CKD) Drugs Sales by Country (2023-2028) & (K Units) Table 67. North America Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022) & (US$ Million) Table 68. North America Chronic Kidney Disease (CKD) Drugs Revenue by Country (2023-2028) & (US$ Million) Table 69. Europe Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) & (K Units) Table 70. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company (2017-2022) Table 71. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) & (US$ Million) Table 72. Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2017-2022) Table 73. Europe Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units) Table 74. Europe Chronic Kidney Disease (CKD) Drugs Sales by Type (2023-2028) & (K Units) Table 75. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 76. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 77. Europe Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units) Table 78. Europe Chronic Kidney Disease (CKD) Drugs Sales by Application (2023-2028) & (K Units) Table 79. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 80. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 81. Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022) & (K Units) Table 82. Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2023-2028) & (K Units) Table 83. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022) & (US$ Million) Table 84. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Country (2023-2028) & (US$ Million) Table 85. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) & (K Units) Table 86. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company (2017-2022) Table 87. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) & (US$ Million) Table 88. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2017-2022) Table 89. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units) Table 90. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Type (2023-2028) & (K Units) Table 91. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 92. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 93. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units) Table 94. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Application (2023-2028) & (K Units) Table 95. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 96. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 97. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Region (2017-2022) & (K Units) Table 98. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Region (2023-2028) & (K Units) Table 99. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Region (2017-2022) & (US$ Million) Table 100. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Region (2023-2028) & (US$ Million) Table 101. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) & (K Units) Table 102. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company (2017-2022) Table 103. Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) & (US$ Million) Table 104. Latin America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2017-2022) Table 105. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units) Table 106. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Type (2023-2028) & (K Units) Table 107. Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 108. Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 109. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units) Table 110. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Application (2023-2028) & (K Units) Table 111. Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 112. Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 113. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022) & (K Units) Table 114. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Country (2023-2028) & (K Units) Table 115. Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022) & (US$ Million) Table 116. Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Country (2023-2028) & (US$ Million) Table 117. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2022) & (K Units) Table 118. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company (2017-2022) Table 119. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2022) & (US$ Million) Table 120. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2017-2022) Table 121. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units) Table 122. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Type (2023-2028) & (K Units) Table 123. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 124. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 125. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units) Table 126. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Application (2023-2028) & (K Units) Table 127. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 128. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 129. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022) & (K Units) Table 130. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2023-2028) & (K Units) Table 131. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022) & (US$ Million) Table 132. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Country (2023-2028) & (US$ Million) Table 133. Pfizer, Inc. Corporation Information Table 134. Pfizer, Inc. Description and Overview Table 135. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 136. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Product and Services Table 137. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table 138. Pfizer, Inc. Recent Developments Table 139. Amgen Corporation Information Table 140. Amgen Description and Overview Table 141. Amgen Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 142. Amgen Chronic Kidney Disease (CKD) Drugs Product and Services Table 143. Amgen Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table 144. Amgen Recent Developments Table 145. Roche Corporation Information Table 146. Roche Description and Overview Table 147. Roche Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 148. Roche Chronic Kidney Disease (CKD) Drugs Product and Services Table 149. Roche Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table 150. Roche Recent Developments Table 151. GlaxoSmithKline (GSK) Corporation Information Table 152. GlaxoSmithKline (GSK) Description and Overview Table 153. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 154. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Product and Services Table 155. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table 156. GlaxoSmithKline (GSK) Recent Developments Table 157. Allergan Corporation Information Table 158. Allergan Description and Overview Table 159. Allergan Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 160. Allergan Chronic Kidney Disease (CKD) Drugs Product and Services Table 161. Allergan Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table 162. Allergan Recent Developments Table 163. AbbVie Corporation Information Table 164. AbbVie Description and Overview Table 165. AbbVie Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 166. AbbVie Chronic Kidney Disease (CKD) Drugs Product and Services Table 167. AbbVie Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table 168. AbbVie Recent Developments Table 169. Kissei Pharmaceutical Co., Ltd. Corporation Information Table 170. Kissei Pharmaceutical Co., Ltd. Description and Overview Table 171. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 172. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Product and Services Table 173. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table 174. Kissei Pharmaceutical Co., Ltd. Recent Developments Table 175. Key Raw Materials Lists Table 176. Raw Materials Key Suppliers Lists Table 177. Chronic Kidney Disease (CKD) Drugs Distributors List Table 178. Chronic Kidney Disease (CKD) Drugs Customers List Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Chronic Kidney Disease (CKD) Drugs Product Picture Figure 2. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type in 2021 & 2028 Figure 3. ACE Inhibitors Product Picture Figure 4. Angiotensin-II Receptor Blockers Product Picture Figure 5. Calcium Channel Blockers Product Picture Figure 6. Beta Blockers: BREVIBLOC, Bystolic Product Picture Figure 7. Others Product Picture Figure 8. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application in 2021 & 2028 Figure 9. Hospitals Use Case Figure 10. Specialty Clinics Use Case Figure 11. Chronic Kidney Disease (CKD) Drugs Report Years Considered Figure 12. Global Chronic Kidney Disease (CKD) Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Chronic Kidney Disease (CKD) Drugs Market Size 2017-2028 (US$ Million) Figure 14. Global Chronic Kidney Disease (CKD) Drugs Sales (2017-2022) & (K Units) Figure 15. Global Chronic Kidney Disease (CKD) Drugs Market Size Market Share by Region: 2021 VS 2028 Figure 16. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region (2017-2022) Figure 17. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region in 2021 Figure 18. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Region in 2017 VS 2021 Figure 19. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers in 2021 Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Kidney Disease (CKD) Drugs Sales in 2021 Figure 21. Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers in 2021 Figure 22. Chronic Kidney Disease (CKD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 23. Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Type (2017-2022) Figure 24. Global Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate by Type in 2017 & 2021 Figure 25. Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Application (2017-2022) Figure 26. Global Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate by Application in 2017 & 2021 Figure 27. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2028) Figure 28. North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2017-2028) Figure 29. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2028) Figure 30. North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application (2017-2028) Figure 31. North America Chronic Kidney Disease (CKD) Drugs Sales Share by Country (2017-2028) Figure 32. North America Chronic Kidney Disease (CKD) Drugs Revenue Share by Country (2017-2028) Figure 33. United States Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 34. Canada Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 35. Mexico Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 36. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2028) Figure 37. Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2017-2028) Figure 38. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2028) Figure 39. Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application (2017-2028) Figure 40. Europe Chronic Kidney Disease (CKD) Drugs Sales Share by Country (2017-2028) Figure 41. Europe Chronic Kidney Disease (CKD) Drugs Revenue Share by Country (2017-2028) Figure 42. Germany Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 43. France Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 44. UK Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 45. Italy Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 46. Russia Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 47. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2028) Figure 48. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2017-2028) Figure 49. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2028) Figure 50. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application (2017-2028) Figure 51. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Share by Region (2017-2028) Figure 52. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Share by Region (2017-2028) Figure 53. China Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 54. Japan Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 55. South Korea Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 56. India Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 57. Australia Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 58. Indonesia Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 59. Thailand Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 60. Malaysia Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 61. Philippines Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 62. Vietnam Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 63. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2028) Figure 64. Latin America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2017-2028) Figure 65. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2028) Figure 66. Latin America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application (2017-2028) Figure 67. Latin America Chronic Kidney Disease (CKD) Drugs Sales Share by Country (2017-2028) Figure 68. Latin America Chronic Kidney Disease (CKD) Drugs Revenue Share by Country (2017-2028) Figure 69. Mexico Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 70. Brazil Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 71. Argentina Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 72. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2028) Figure 73. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2017-2028) Figure 74. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2028) Figure 75. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application (2017-2028) Figure 76. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Share by Country (2017-2028) Figure 77. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Share by Country (2017-2028) Figure 78. Turkey Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 79. Saudi Arabia Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 80. UAE Chronic Kidney Disease (CKD) Drugs Revenue (2017-2028) & (US$ Million) Figure 81. Chronic Kidney Disease (CKD) Drugs Value Chain Figure 82. Chronic Kidney Disease (CKD) Drugs Production Process Figure 83. Channels of Distribution Figure 84. Distributors Profiles Figure 85. Bottom-up and Top-down Approaches for This Report Figure 86. Data Triangulation Figure 87. Key Executives Interviewed

Pfizer, Inc. Amgen Roche GlaxoSmithKline (GSK) Allergan AbbVie Kissei Pharmaceutical Co., Ltd.